Text size Kodak is making a foray into generic drug ingredients Daniel Acker / Bloomberg Eastman Kodak’s shares are enjoying a renaissance. Shares rose 160% on Wednesday morning, taking advantage of the incredible gain of more than 200% on Tuesday. New capital and new business are the reasons for the …
Read More »